Pregabalin is one of the most frequently prescribed medications in the United Kingdom for conditions involving nerve pain, epilepsy, and anxiety. Sold under the brand name Lyrica and also available as a generic, it is used by hundreds of thousands of adults across the NHS every year. Yet despite its widespread use, many patients and caregivers remain uncertain about one critical question: what is the maximum dose of pregabalin for adults in the UK?
This guide provides a clear, up-to-date overview of UK-specific prescribing limits for pregabalin, how doses vary by condition, what happens when renal function is impaired, and the safety considerations that every patient should understand before and during treatment.
Pregabalin in the UK: Regulatory Status and NHS Prescribing
In the UK, pregabalin is licensed and regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). It is classified as a Schedule 3 Controlled Drug under the Misuse of Drugs Regulations 2001, meaning it is subject to specific prescribing controls due to recognised risks of misuse and dependence.
The NHS prescribes pregabalin in accordance with guidance from the National Institute for Health and Care Excellence (NICE) and the British National Formulary (BNF). These guidelines specify the conditions for which pregabalin is licensed in the UK, the recommended starting doses, the titration schedule, and crucially the maximum doses that should not be exceeded in adult patients.
What Is the Maximum Dose of Pregabalin for Adults in the UK?
For the majority of adult indications approved in the UK, the maximum recommended daily dose of pregabalin is 600 mg per day. This overarching limit applies across conditions including neuropathic pain, epilepsy, and generalised anxiety disorder (GAD).
However, the maximum dose is not uniform across all uses. For fibromyalgia which is treated off-label in the UK clinical practice and available evidence suggest a lower ceiling of around 450 mg per day. It is important to note that doses should always be the lowest effective dose; reaching the maximum is not always necessary or advisable.
The table below provides a comprehensive breakdown of maximum doses by indication, as aligned with BNF and MHRA guidance:
| Condition | Starting Dose | Effective Dose Range | Maximum Daily Dose (UK) | Doses Per Day |
| Peripheral Neuropathic Pain (e.g. Diabetic Neuropathy) | 75 mg twice daily | 150–300 mg/day | 600 mg/day | 2–3 |
| Central Neuropathic Pain (e.g. Spinal Cord Injury) | 75 mg twice daily | 150–600 mg/day | 600 mg/day | 2–3 |
| Post-Herpetic Neuralgia | 75 mg twice daily or 50 mg three times daily | 150–300 mg/day | 600 mg/day | 2–3 |
| Epilepsy (Adjunctive Therapy) | 75 mg twice daily | 150–600 mg/day | 600 mg/day | 2–3 |
| Generalised Anxiety Disorder (GAD) | 150 mg/day (divided) | 300–450 mg/day | 600 mg/day | 2–3 |
| Fibromyalgia (off-label in UK) | 75 mg twice daily | 300–450 mg/day | 450 mg/day* | 2–3 |
* Fibromyalgia is not a licensed indication in the UK; dosing is based on clinical judgement and available trial data.
Read More :- Say Goodbye to Sciatic Nerve Pain in Just 10 Minutes with This Natural Method
How Is Pregabalin Dosed and Titrated in UK Clinical Practice?
UK prescribers follow a gradual titration process to minimise side effects such as dizziness and sedation. Rushing to higher doses too quickly increases the risk of adverse effects and poor tolerability.
A standard titration schedule for an adult with neuropathic pain might look like this:
Week 1: 75 mg twice daily (150 mg/day)
Week 2–3: 150 mg twice daily (300 mg/day), if tolerated
Week 4 onwards: Up to 300 mg twice daily (600 mg/day), only if further benefit is needed and tolerability allows
For GAD, the starting dose is typically 150 mg per day in divided doses, with increments up to 600 mg/day depending on response. Titration should take place over a minimum of one week between dose increases.
Dose Adjustments for Renal Impairment in UK Adults
Because pregabalin is eliminated almost entirely by the kidneys unchanged, renal function is a critical factor in determining the safe maximum dose. The BNF provides specific dose reduction guidance based on creatinine clearance (CrCl):
- CrCl ≥ 60 mL/min: No adjustment required — standard maximum of 600 mg/day applies
- CrCl 30–59 mL/min: Maximum dose reduced to 300 mg/day
- CrCl 15–29 mL/min: Maximum dose reduced to 150 mg/day
- CrCl < 15 mL/min: Maximum dose reduced to 75 mg/day
- Haemodialysis patients: A supplemental dose is required after each dialysis session, as pregabalin is effectively cleared by dialysis
Failing to adjust pregabalin doses in patients with renal impairment can lead to drug accumulation, resulting in severe sedation, confusion, and respiratory complications. Renal function should be assessed before initiating treatment and monitored periodically thereafter, particularly in elderly patients.
Pregabalin and the Risk of Dependence: A UK Perspective
The reclassification of pregabalin as a Schedule 3 Controlled Drug in the UK in April 2019 reflected growing concern about misuse, particularly in populations with a history of substance use disorders. Reports of pregabalin being used recreationally often in combination with opioids or alcohol to enhance sedative effects prompted significant changes to how it is prescribed.
Under current UK regulations:
- Pregabalin prescriptions cannot be issued for more than 30 days at a time in most circumstances
- Repeat prescriptions require a new signed prescription from the prescriber
- Electronic prescribing via the Controlled Drug schedule means prescriptions cannot be faxed or emailed
Patients who have been using pregabalin for extended periods should never stop taking it abruptly. Withdrawal symptoms including anxiety, insomnia, sweating, and in severe cases, seizures can occur even when the medication has been taken at therapeutic doses. A supervised tapering schedule is always recommended.
Side Effects Associated With Higher Doses
As the dose of pregabalin increases towards the maximum, the likelihood of side effects rises correspondingly. The most commonly reported adverse effects at higher doses include:
- Dizziness and loss of balance (ataxia)
- Excessive drowsiness or sedation
- Blurred or double vision
- Weight gain and increased appetite
- Peripheral oedema (swelling of the hands, feet, and legs)
- Cognitive difficulties, including problems with concentration and memory
- Mood changes, including low mood or, rarely, suicidal ideation
The MHRA requires prescribers to counsel patients about the risks of driving and operating machinery while taking pregabalin, particularly at higher doses. Patients should be reviewed regularly to assess whether dose reductions are appropriate as treatment progresses.
When Should You Speak to Your GP or Pharmacist?
You should seek advice from your GP, specialist, or pharmacist if any of the following apply:
- Your current dose is not adequately controlling your pain, seizures, or anxiety
- You are experiencing significant side effects that are impacting your daily life
- You have been diagnosed with chronic kidney disease or your renal function has recently been tested and found to be reduced
- You are taking other sedating medications, including opioids, benzodiazepines, or sleeping tablets
- You are pregnant, planning a pregnancy, or breastfeeding — pregabalin has teratogenic potential and is not recommended in pregnancy
- You feel you may be relying on pregabalin beyond its prescribed purpose
Conclusion
In the UK, the maximum dose of pregabalin for adults is 600 mg per day for most licensed indications, though this ceiling is lower for certain conditions and must be significantly reduced for patients with renal impairment. Pregabalin is a powerful and effective medication when used correctly but its status as a controlled drug reflects the importance of careful, supervised prescribing.
Always take pregabalin exactly as prescribed. Never self-adjust your dose based on internet research, and report any concerns to your healthcare provider promptly. The goal is always to find the lowest effective dose that provides meaningful relief not to push towards the maximum.
Disclaimer: This blog is intended for informational purposes only and does not constitute medical or pharmaceutical advice. Dosing information is based on UK BNF and MHRA guidelines current at the time of writing. Always consult your GP, specialist, or pharmacist before making any changes to your medication.
Read More :- Why Pregabalin Is Commonly Prescribed for Neuropathic Pain